Status:
TERMINATED
Unrestricted Rehabilitation Pathway Following Total Hip Replacement
Lead Sponsor:
University of Manchester
Conditions:
Total Hip Replacement
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of ReHip2 is to explore the impact on function and quality of life in patients following Total Hip Replacement (THR). A randomised controlled trial will compare two different rehabilitatio...
Detailed Description
Dislocation of the hip following total hip replacement (THR) is the sole reason for the endorsement of precautions following THR. This has remained unchanged sine the first hip replacement in 1969. T...
Eligibility Criteria
Inclusion
- Adult participants over the age of 18 years will be included.
- All participants should be proceeding with routine care unilateral (one side only) primary THR for treatment of osteoarthritis
- The patients operating consultant agreed to involvement of their patients in the study.
- All subjects assessed during routine pre-operative assessment in their respective hospital will have been assigned an American Society of Anesthesiologists (ASA) up to grade 3 out of a total of 6 (defined as 'severe systemic disease that limits activity but is not incapacitating').
- Patients who have undergone previous hip injection for treatment of osteoarthritic symptoms.
- All surgical approaches (anterior, lateral and posterior), cemented and un-cemented prostheses and all size femoral head size.
Exclusion
- The operating consultant declined participation in the study.
- The participant previously had hip surgery to the same hip, including arthroscopy, revision hip surgery or treatment for Avascular Necrosis.
- ASA grade 4 or above 'A patient with severe systemic disease that is a constant threat to life.'
- Patients with specifically identified increased risk of dislocation (for example neuromuscular disease, hypermobility)
- Complex primary hip replacement (THR with femoral osteotomy or structural bone grafting / augmentation of acetabulum)
- Patients unable to complete the postal outcome measures.
- Any patient with pre-operative cognitive impairment (Dementia or Learning disabilities).
- Patients undergoing THR for treatment of fractured neck of femur.
Key Trial Info
Start Date :
August 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT03833258
Start Date
August 22 2019
End Date
April 30 2021
Last Update
November 18 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS Foundation Trust
Manchester, United Kingdom, M13 9WL
2
Wrightington Wigan and Leigh NHS Foundation Trust
Wigan, United Kingdom, WN6 9EP